A master protocol to test the impact of discontinuing chronic therapies in people with cystic fibrosis on highly effective CFTR modulator therapy (SIMPLIFY)

Project: Research project

Project Details


Study Site will perform the research and administrative work ("Work") as specified herein, including, without limitation, providing all reasonably necessary facilities, equipment and materials; performing all reasonably necessary activities; keeping appropriate records; and reporting the results pursuant to the conduct of a scientific investigation involving human subjects ("Patients") in accordance with the applicable Protocol and other specific instructions. The Work to be conducted by Study Site under this Agreement shall be in accordance with (i) the clinical trial Protocol, as may be amended from time to time in writing, and (ii) specific instructions regarding patient safety or technical and scientific aspects of the Study as may be transmitted to the Study Site by or on the behalf of Seattle Children's.
Effective start/end date12/17/2012/16/23


  • Seattle Children's (PO Number: 12481SUB)
  • Cystic Fibrosis Foundation (PO Number: 12481SUB)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.